ConvaTec Group PLC (CTEC) Insider Purchases £9,914.16 in Stock
ConvaTec Group PLC (LON:CTEC) insider Ros Rivaz purchased 4,908 shares of the business’s stock in a transaction dated Monday, December 4th. The shares were acquired at an average price of GBX 202 ($2.72) per share, with a total value of £9,914.16 ($13,343.42).
ConvaTec Group PLC (LON CTEC) traded up GBX 2.80 ($0.04) during mid-day trading on Tuesday, reaching GBX 207 ($2.79). The company had a trading volume of 4,222,692 shares, compared to its average volume of 8,360,000. ConvaTec Group PLC has a fifty-two week low of GBX 181.40 ($2.44) and a fifty-two week high of GBX 349.10 ($4.70).
Several research firms have weighed in on CTEC. Numis Securities reissued a “reduce” rating and issued a GBX 180 ($2.42) target price on shares of ConvaTec Group in a research note on Tuesday. lowered ConvaTec Group to a “hold” rating and dropped their price target for the stock from GBX 345 ($4.64) to GBX 240 ($3.23) in a research report on Tuesday, October 17th. Deutsche Bank raised their price target on ConvaTec Group from GBX 330 ($4.44) to GBX 335 ($4.51) and gave the stock a “buy” rating in a research report on Monday, August 21st. Peel Hunt raised their price target on ConvaTec Group from GBX 380 ($5.11) to GBX 390 ($5.25) and gave the stock a “buy” rating in a research report on Wednesday, August 9th. Finally, Goldman Sachs Group reaffirmed a “buy” rating and set a GBX 330 ($4.44) price target on shares of ConvaTec Group in a research report on Monday, September 11th. Two analysts have rated the stock with a sell rating, six have assigned a hold rating and three have issued a buy rating to the company. The stock presently has an average rating of “Hold” and an average price target of GBX 251.20 ($3.38).
ConvaTec Group Company Profile
ConvaTec Group Plc is a medical product and technology company. The Company focuses on therapies for the management of chronic conditions, including products used for advanced chronic and acute wound care, ostomy care, continence and critical care and infusion devices used in the treatment of diabetes and other conditions.
Receive News & Ratings for ConvaTec Group PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ConvaTec Group PLC and related companies with MarketBeat.com's FREE daily email newsletter.